Everest Organics hit an upper circuit of 5% at Rs 257.15 after the company announced that it has received approval for its Rabeprazole Sodium API from the Korea Drug Master File (KDMF).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback